Avai Bio, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVAI research report →
About the company
Avai Bio, Inc. operates as a holding company primarily focused on creating websites and mobile applications that offer users personalized and convenient experiences. Its business activities include providing IT consulting services and making artificial intelligence accessible to the general public.
- CEO
- Chris Winter
- IPO
- 2020
- Employees
- 1
- HQ
- Vilnius, NV, LT
Price Chart
- Market Cap
- $18.66M
- P/E
- -18.09
- P/S
- 0.00
- P/B
- -6.67
- EV/EBITDA
- -21.22
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 47.64%
- ROIC
- 75.66%
- Revenue
- $0 · 0.00%
- Net Income
- $-1,142,115 · 46.34%
- EPS
- $-0.01 · 63.82%
- Op Income
- $-1,532,792
- FCF YoY
- 21.12%
- 52W High
- $0.80
- 52W Low
- $0.13
- 50D MA
- $0.23
- 200D MA
- $0.35
- Beta
- 0.84
- Avg Volume
- 156.38K
Get TickerSpark's AI analysis on AVAI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our AVAI coverage
Recent articles, reports, and earnings notes.
No research on AVAI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AVAI report →Similar companies
Peers in the same neighborhood.